More than 60 cases filed in the FAERS database detail how patients experienced worsening liver health after taking AbbVie's Mavyret, Merck & Co.'s Zepatier or Gilead's Vosevi.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,